Evidence map›Paper›PMID 25049234›Full record

ArticleThe Journal of biological chemistry2014

Dual functions of the trans-2-enoyl-CoA reductase TER in the sphingosine 1-phosphate metabolic pathway and in fatty acid elongation.

Takeshi Wakashima, Kensuke Abe, Akio Kihara

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. A fat-fueled fatality.Nature chemical biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Research (Washington, D.C.) · 2022
    Article
  10. S1P and plasmalogen derived fatty aldehydes in cellular signaling and functions.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2020
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Monitoring the SphingolipidFrontiers in cell and developmental biology · 2019
    Article
  16. Bta-miR-124a Affects Lipid Metabolism by RegulatingBioMed research international · 2019
    Article
  17. Article
  18. Sphingolipids and their metabolism in physiology and disease.Nature reviews. Molecular cell biology · 2018
    Review
  19. Article
  20. Phytosphingosine degradation pathway includes fatty acid α-oxidation reactions in the endoplasmic reticulum.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Takeshi WakashimaFrom the Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12-jo, Nishi 6-chome, Kita-ku, Sapporo 060-0812, Japan.
Kensuke AbeFrom the Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12-jo, Nishi 6-chome, Kita-ku, Sapporo 060-0812, Japan.
Akio KiharaFrom the Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12-jo, Nishi 6-chome, Kita-ku, Sapporo 060-0812, Japan kihara@pharm.hokudai.ac.jp.
Hokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sphingolipid metabolite sphingosine 1-phosphate (S1P) functions as a lipid mediator and as a key intermediate of the sole sphingolipid to glycerophospholipid metabolic pathway (S1P metabolic pathway). In this pathway, S1P is converted to palmitoyl-CoA through 4 reactions, then incorporated mainly into glycerophospholipids. Although most of the genes responsible for the S1P metabolic pathway have been identified, the gene encoding the trans-2-enoyl-CoA reductase, responsible for the saturation step (conversion of trans-2-hexadecenoyl-CoA to palmitoyl-CoA) remains unidentified. In the present study, we show that TER is the missing gene in mammals using analyses involving yeast cells, deleting the TER homolog TSC13, and TER-knockdown HeLa cells. TER is known to be involved in the production of very long-chain fatty acids (VLCFAs). A significant proportion of the saturated and monounsaturated VLCFAs are used for sphingolipid synthesis. Therefore, TER is involved in both the production of VLCFAs used in the fatty acid moiety of sphingolipids as well as in the degradation of the sphingosine moiety of sphingolipids via S1P.

Indexed as

Metabolic Networks and PathwaysAldehyde-LyasesAnimalsFatty AcidsGene Expression Regulation, EnzymologicHeLa CellsHep G2 CellsHumansLysophospholipidsMutationOxidoreductases Acting on CH-CH Group DonorsPC12 CellsPhosphotransferases (Alcohol Group Acceptor)RatsReverse Transcriptase Polymerase Chain ReactionRNA InterferenceAldehyde-LyasesFatty AcidsLysophospholipidsOxidoreductases Acting on CH-CH Group DonorsPhosphotransferases (Alcohol Group Acceptor)Saccharomyces cerevisiae ProteinsSphingolipidsSphingosinesphingosine 1-phosphatesphingosine 1-phosphate lyase (aldolase)Sphingosine Kinasetrans-2-enoyl-CoA reductase (NADPH)TSC13 protein, S cerevisiaeFatty AcidLipidLipid MetabolismLysophospholipidPhospholipidSphingolipidSphingosine 1-Phosphate (S1P)Very Long-chain Fatty AcidYeast

Identifiers

PMID25049234
PMCPMC4155643
OpenAlexW2031294360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.